Skip to main content

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates

Explore URMC
menu
URMC / Research / Clinical Trials / Study Details

Effects of Hyperbaric Oxygen (HBO) on Blood Count Recovery After Autologous Hematopoietic Stem Cell (HSPC) Transplant for Multiple Myeloma

Research Question:
What is the effect of one hyperbaric oxygen therapy session prior to hematopoetic stem cell infusion compared to no hyperbaric oxygen therapy session before hematopoetic stem cell infusion?

Basic Study Information

Purpose:
Patients with Multiple Myeloma who are considered for high-dose therapy and autologous transplantation at the bone marrow transplant clinic at the Wilmot Cancer Institute (WCI) will be be approached to participate in this trial. Eligible patients who choose to participate will be randomized so that half receive one hyperbaric oxygen therapy session prior to hematopoetic stem cell infusion and half will not. All subjects will have their blood counts monitored closely and time to count recovery will be compared between the two groups.

Location: University of Rochester Medical Center
Study Reference #: UBMT17083-

Lead Researcher (Principal Investigator)

Lead Researcher:  Omar Aljitawi

Study Contact Information

Study Coordinator: katherine Nedrow
Phone: (585) 275-3893
Email: Katherine_Nedrow@URMC.Rochester.edu

Additional Study Details

Return to Search